Detection and Quantification of Atrial Fibrillation in High-risk Patients Using a Smartwatch Wearable (Apple Watch)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 436 participants.
Also called NCT05686330
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 436 participants
- Sponsor
- Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
- Registry
-
NCT05686330
-
- Other papers using this trial's data
- Enhanced Detection and Prompt Diagnosis of Atrial Fibrillation Using Apple Watch: A Randomized Controlled Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT05686330. Randomized; no masking; primary purpose diagnostic. Start 2022-11-16 (actual); primary completion 2025-07-17 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Detection and Quantification of Atrial Fibrillation in High-risk Patients Using a Smartwatch Wearable (Apple Watch)
- Acronym
- EQUAL
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Apple Watch
- Lead sponsor
- Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Record details
- Record id
cardio:ct-nct05686330- Content hash
0e9f09b11473fcc9d5a60e1311867ed6873ac950d7f037c64a48a7f04b89c19c